chr11-2572057-G-A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong
The NM_000218.3(KCNQ1):c.728G>A(p.Arg243His) variant causes a missense change. The variant allele was found at a frequency of 0.00000806 in 1,612,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R243C) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.728G>A | p.Arg243His | missense_variant | 5/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.728G>A | p.Arg243His | missense_variant | 5/16 | 1 | NM_000218.3 | ENSP00000155840 | P1 | |
KCNQ1 | ENST00000335475.6 | c.347G>A | p.Arg116His | missense_variant | 5/16 | 1 | ENSP00000334497 | |||
KCNQ1 | ENST00000496887.7 | c.467G>A | p.Arg156His | missense_variant | 6/16 | 5 | ENSP00000434560 | |||
KCNQ1 | ENST00000646564.2 | c.478-11378G>A | intron_variant | ENSP00000495806 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 249024Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135222
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1460642Hom.: 0 Cov.: 32 AF XY: 0.00000826 AC XY: 6AN XY: 726644
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74332
ClinVar
Submissions by phenotype
Jervell and Lange-Nielsen syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 18, 2019 | The p.Arg243His variant in KCNQ1 has been reported in 4 individuals with Jervell and Lange-Nielsen syndrome (JLNS): It was identified in the homozygous state in 3 Turkish individuals from consanguineous families (Tyson 1997, Tyson 2000, Bostan 2013, Kılıç 2014) and in the compound heterozygous state in 1 French individual (Mohammad-Panah 1999, Chouabe 2000). Relatives who were heterozygous carriers of this variant were either clinically asymptomatic for LQTS or had a modestly prolonged QT interval (Larsen 1999, Ning 2003) suggesting reduced penetrance and variable expressivity. This variant has also been reported in one individual with long QT syndrome (LQTS; Kobori 2004, Itoh 2009). In vitro functional studies support an impact on protein function (Mohammad-Panah 1999, Chouabe 2000, Huang 2001, Itoh 2009. The p.Arg243His variant has been identified in 0.004% (1/24684) of African chromosomes and 0.003% (1/30584) of South Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org) and is present in ClinVar (Variation ID: 53092). Computational prediction tools and conservation analysis suggest that this variant may impact the protein. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive JLNS (ACMG/AMP Criteria applied: PM2, PM3, PP3, PS3_Supporting), but its clinical significance in LQTS is uncertain (ACMG/AMP Criteria applied: PM2, PP3, PS3_Supporting). - |
Pathogenic, criteria provided, single submitter | research | Dept of Medical Biology, Uskudar University | Jan 08, 2024 | Criteria: PS3_Moderate, PM1, PM2, PM3_Strong, PP3 - |
Jervell and Lange-Nielsen syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Jan 03, 2022 | The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 26022593, 23400408, PS4_S). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.954, 3CNET: 0.984, PP3_P). A missense variant is a common mechanism associated with Jervell and Lange-Nielsen syndrome (PP2_P). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000007, PM2_M). A different missense change at the same codon has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000053091, PMID:10409658,16922724,19490272, PM5_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
KCNQ1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 19, 2023 | The KCNQ1 c.728G>A variant is predicted to result in the amino acid substitution p.Arg243His. This variant was reported in the homozygous or compound heterozygous state with a second pathogenic KCNQ1 variant in at least three unrelated individuals with Jervell and Lange-Nielsen syndrome (Chouabe et al. 2000. PubMed ID: 10728423; Bostan et al. 2013. PubMed ID: 23400408; Kılıç et al. 2014. PubMed ID: 26022593). Of note, heterozygous carriers have been documented with a wide range of phenotypic variability, ranging from asymptomatic, borderline QTc interval, to a clinical diagnosis of long QT syndrome (Mohammad-Panah et al. 1999. PubMed ID: 10090886; Itoh et al. 2009. PubMed ID: 19843919; Bostan et al. 2013. PubMed ID: 23400408; Table S1, Schwartz et al. 2021. PubMed ID: 34505893; Saat et al. 2022. PubMed ID: 35703482). Functional studies support the pathogenicity of this variant (Chouabe et al. 2000. PubMed ID: 10728423; Huang et al. 2001. PubMed ID: 11530100; Park et al. 2005. PubMed ID: 15746441; Coyan et al. 2014. PubMed ID: 24681627). This variant is reported in 0.0041% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-2593287-G-A). This variant is interpreted as pathogenic. - |
Long QT syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 18, 2022 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 243 of the KCNQ1 protein (p.Arg243His). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg243 amino acid residue in KCNQ1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10973849, 12877697, 14678125, 15234419, 15466642, 15469540, 15840476, 17470695, 19716085, 19841300, 20167303). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 10090886, 11530100, 15746441, 15935335, 19843919, 24681627). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 53092). This missense change has been observed in individuals with Jervell and Lange-Nielsen syndrome (PMID: 10728423, 23400408, 26022593). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 25, 2022 | The p.R243H variant (also known as c.728G>A), located in coding exon 5 of the KCNQ1 gene, results from a G to A substitution at nucleotide position 728. The arginine at codon 243 is replaced by histidine, an amino acid with highly similar properties. This alteration is located in the S4 transmembrane domain and has been reported in trans with another pathogenic KCNQ1 mutation in a proband with Jervell and Lange-Nielsen syndrome (JLNS) (Chouabe C et al. Cardiovasc. Res., 2000 Mar;45:971-80). This variant has also been detected in the homozygous state in multiple Turkish probands with JLNS, while some heterozygous relatives were reported to have QTc intervals within normal limits (Huang L et al. Cardiovasc. Res., 2001 Sep;51:670-80; Bostan O et al. Pediatr Cardiol, 2013 Feb;34:2063-7; Klç E et al. Turk. J. Pediatr.;56:542-5). General population frequency data for the Turkish population is limited and the possibility that this alteration is common in the Turkish subpopulation can not be excluded. This alteration has been identified in the heterozygous state in a patient with drug-induced long QT syndrome (Kobori A et al. J. Cardiovasc. Electrophysiol., 2004 Feb;15:190-9). A number of functional studies suggest that this alteration results in deficient protein function (Mohammad-Panah R et al. Am. J. Hum. Genet., 1999 Apr;64:1015-23; Chouabe C et al. Cardiovasc. Res., 2000 Mar;45:971-80; Huang L et al. Cardiovasc. Res., 2001 Sep;51:670-80; Wilson AJ et al. Cardiovasc. Res., 2005 Aug;67:476-86; Park KH et al. Circ. Res., 2005 Apr;96:730-9; Itoh H et al. Circ Arrhythm Electrophysiol, 2009 Oct;2:511-23). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Cardiac arrhythmia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 07, 2022 | This missense variant is located in the fourth segment (S4) of the transmembrane domain of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Functional studies have shown that this variant causes a defect in protein trafficking (PMID:15935335), reduced binding affinity for PIP2 (PMID: 15746441, 24681627), and decreased current compared to wild type (PMID: 10090886, 15746441, 19843919, 24681627). This variant has been reported in at least eight unrelated heterozygous individuals affected with long QT syndrome (PMID: 15028050, 19843919, 32893267). This variant has been also reported in homozygous or in compound heterozygous state with a known pathogenic KCNQ1 variant in four unrelated individuals affected with Jervell and Lange-Nielsen Syndrome, a severe form of long QT syndrome that also involves hearing loss (PMID: 10090886, 10728423, 23400408, 26022593, 29037160). Four heterozygous relatives from these families and another unrelated heterozygous individual (PMID:19843919) were reported to be either asymptomatic or have a modestly prolonged QT interval, suggesting reduced penetrance. This variant has been identified in 2/280356 chromosomes in the general population by the Genome Aggregation Database (gnomAD). A different missense variant occurring at the same codon, p.Arg243Cys, is known to cause long QT syndrome (Clinvar variation ID: 53091), indicating that arginine at this position is important for KCNQ1 protein function. Based on the available evidence, this variant is classified as Pathogenic. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported in the following publications (PMID:9482580;PMID:10090886;PMID:11530100;PMID:15028050;PMID:18174212;PMID:19843919;PMID:10728423;PMID:11140949;PMID:15935335;PMID:10409658;PMID:15746441). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at